In vitro and ex vivo activity of the fluoroquinolone DC-159a against mycobacteria

Antimicrobial resistance is a global health problem. In 2021, it was estimated almost half a million of multidrug-resistant tuberculosis (MDR-TB) cases. Besides, non-tuberculous mycobacteria (NTM) are highly resistant to several drugs and the emergence of fluoroquinolone (FQ) resistant M. tuberculos...

Full description

Bibliographic Details
Main Authors: Imperiale, Belen Rocio, Mancino, María Belén, Moyano, Roberto Damian, de la Barrera, Silvia, Morcillo, Nora
Format: info:ar-repo/semantics/artículo
Language:Inglés
Published: Japan Antibiotics Research Association 2024
Subjects:
Online Access:http://hdl.handle.net/20.500.12123/18738
https://www.nature.com/articles/s41429-024-00709-3
https://doi.org/10.1038/s41429-024-00709-3

Similar Items: In vitro and ex vivo activity of the fluoroquinolone DC-159a against mycobacteria